Octave Bioscience Partners with Quest Diagnostics to Expand Access to Multiple Sclerosis Disease Activity Test Nationwide

Octave Bioscience has formed a strategic collaboration with Quest Diagnostics to expand patient access to the Octave Multiple Sclerosis Disease Activity Test across the US. The test is a clinically and analytically validated multi-analyte blood test that provides reliable, objective data to support treatment decisions. It measures 18 validated protein biomarkers, giving a clear view of disease activity. The test is reimbursed by multiple payers and supported by a patient affordability program.